-
2
-
-
38949215535
-
Thrombin and protease-activated receptors (PARs) in atherothrombosis
-
Martorell L, Martínez-González J, Rodríguez C, et al. Thrombin and protease-activated receptors (PARs) in atherothrombosis. Thromb Haemost 2008; 99: 305-315.
-
(2008)
Thromb Haemost
, vol.99
, pp. 305-315
-
-
Martorell, L.1
Martínez-González, J.2
Rodríguez, C.3
-
3
-
-
28344436780
-
Protease-activated receptors in hemostasis, thrombosis and vascular biology
-
Coughlin SR. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 2005; 3: 1800-1814.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 1800-1814
-
-
Coughlin, S.R.1
-
4
-
-
33748495552
-
Protease-activated receptors in cardiovascular diseases
-
Leger AJ, Covic L, Kuliopulos A. Protease-activated receptors in cardiovascular diseases. Circulation 2006, 114: 1070-1077.
-
(2006)
Circulation
, vol.114
, pp. 1070-1077
-
-
Leger, A.J.1
Covic, L.2
Kuliopulos, A.3
-
5
-
-
47149108319
-
Pharmacological strategies for inhibition of thrombin activity
-
Alban S. Pharmacological strategies for inhibition of thrombin activity. Curr Pharm Des 2008; 14: 1152-1175.
-
(2008)
Curr Pharm Des
, vol.14
, pp. 1152-1175
-
-
Alban, S.1
-
6
-
-
68349093744
-
Novel anticoagulants in clinical development: Focus on factor Xa and direct thrombin inhibitors
-
Steffel J, Lüscher TF. Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors. J Cardiovasc Med 2009; 10: 616-623.
-
(2009)
J Cardiovasc Med
, vol.10
, pp. 616-623
-
-
Steffel, J.1
Lüscher, T.F.2
-
7
-
-
0141484541
-
Thrombin interactions
-
Di Cera E. Thrombin interactions. Chest 2003; 124: 11S-17S.
-
(2003)
Chest
, vol.124
-
-
Di Cera, E.1
-
8
-
-
17644371341
-
Exosite-driven substrate specificity and function in coagulation
-
Krishnaswamy S. Exosite-driven substrate specificity and function in coagulation. J Thromb Haemost 2005; 3: 54-67.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 54-67
-
-
Krishnaswamy, S.1
-
9
-
-
34250778996
-
Exosites in the substrate specificity of blood coagulation reactions
-
Bock PE, Panizzi P, Verhamme IM. Exosites in the substrate specificity of blood coagulation reactions. J Thromb Haemost 2007; 5: S81-S94.
-
(2007)
J Thromb Haemost
, vol.5
-
-
Bock, P.E.1
Panizzi, P.2
Verhamme, I.M.3
-
10
-
-
0037166273
-
Three-dimensional modeling of thrombin-fibrinogen interaction
-
Rose T, Di Cera E. Three-dimensional modeling of thrombin-fibrinogen interaction. J Biol Chem 2002; 277: 18875-18880.
-
(2002)
J Biol Chem
, vol.277
, pp. 18875-18880
-
-
Rose, T.1
Di Cera, E.2
-
11
-
-
34548456509
-
Beyond unfractionated heparin and warfarin: Current and future advances
-
Hirsh J, O'Donnell M, Eikelboom JW. Beyond unfractionated heparin and warfarin: current and future advances. Circulation 2007; 116: 552-560.
-
(2007)
Circulation
, vol.116
, pp. 552-560
-
-
Hirsh, J.1
O'Donnell, M.2
Eikelboom, J.W.3
-
12
-
-
60549114198
-
Development of new anticoagulants: Present and future
-
Harenberg J. Development of new anticoagulants: present and future. Semin Thromb Hemost 2008; 34: 779-793.
-
(2008)
Semin Thromb Hemost
, vol.34
, pp. 779-793
-
-
Harenberg, J.1
-
14
-
-
0030858230
-
Low-molecular-weight heparins
-
Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997; 337: 688-698.
-
(1997)
N Engl J Med
, vol.337
, pp. 688-698
-
-
Weitz, J.I.1
-
15
-
-
33845480738
-
Direct thrombin inhibitors - A survey of recent developments
-
Schwienhorst A. Direct thrombin inhibitors - a survey of recent developments. Cell Mol Life Sci 2006; 63: 2773-2791.
-
(2006)
Cell Mol Life Sci
, vol.63
, pp. 2773-2791
-
-
Schwienhorst, A.1
-
16
-
-
0024996181
-
The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alphathrombin on fibrinogen
-
Naski MC, Fenton JW 2nd, Maraganore JM, et al. The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alphathrombin on fibrinogen. J Biol Chem 1990; 265: 13484-13489.
-
(1990)
J Biol Chem
, vol.265
, pp. 13484-13489
-
-
Naski, M.C.1
Fenton II, J.W.2
Maraganore, J.M.3
-
17
-
-
0028236301
-
Synthetic peptides and peptidomimetics as substrates and inhibitors of thrombin and other proteases in the blood coagulation system
-
Claeson G. Synthetic peptides and peptidomimetics as substrates and inhibitors of thrombin and other proteases in the blood coagulation system. Blood Coagul Fibrinolysis 1994; 5: 411-436.
-
(1994)
Blood Coagul Fibrinolysis
, vol.5
, pp. 411-436
-
-
Claeson, G.1
-
19
-
-
0027773082
-
Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding
-
Schumacher WA, Steinbacher TE, Heran CL, et al. Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding. J Pharmacol Exp Ther 1993; 267: 1237-1242.
-
(1993)
J Pharmacol Exp Ther
, vol.267
, pp. 1237-1242
-
-
Schumacher, W.A.1
Steinbacher, T.E.2
Heran, C.L.3
-
20
-
-
0030610285
-
Antithrombotic effects of NE-6505, a novel anion-binding exosite inhibitor
-
Muramatsu R, Sasaki M, Watanabe N, et al. Antithrombotic effects of NE-6505, a novel anion-binding exosite inhibitor. Thromb Res 1997; 86: 453-460.
-
(1997)
Thromb Res
, vol.86
, pp. 453-460
-
-
Muramatsu, R.1
Sasaki, M.2
Watanabe, N.3
-
21
-
-
0026780909
-
Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin
-
Kelly AB, Maraganore JM, Bourdon P, et al. Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin. Proc Natl Acad Sci USA 1992; 89: 6040-6044.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 6040-6044
-
-
Kelly, A.B.1
Maraganore, J.M.2
Bourdon, P.3
-
22
-
-
0035501805
-
Molecular mapping of thrombin-receptor interactions
-
Ayala YM, Cantwell AM, Rose T, et al. Molecular mapping of thrombin-receptor interactions. Proteins 2001; 45:107-116.
-
(2001)
Proteins
, vol.45
, pp. 107-116
-
-
Ayala, Y.M.1
Cantwell, A.M.2
Rose, T.3
-
23
-
-
0034611727
-
PAR3 is a cofactor for PAR4 activation by thrombin
-
Nakanishi-Matsui M, Zheng YW, Sulciner DJ, et al. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 2000; 404: 609-613.
-
(2000)
Nature
, vol.404
, pp. 609-613
-
-
Nakanishi-Matsui, M.1
Zheng, Y.W.2
Sulciner, D.J.3
-
24
-
-
0344925961
-
Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage
-
Jacques SL, Kuliopulos A. Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage. Biochem J 2003; 376: 733-740.
-
(2003)
Biochem J
, vol.376
, pp. 733-740
-
-
Jacques, S.L.1
Kuliopulos, A.2
-
25
-
-
0025174706
-
Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin
-
Jakubowski JA, Maraganore JM. Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin. Blood 1990; 75: 399-406.
-
(1990)
Blood
, vol.75
, pp. 399-406
-
-
Jakubowski, J.A.1
Maraganore, J.M.2
-
26
-
-
0026575221
-
Selection of single-stranded DNA molecules that bind and inhibit human thrombin
-
Bock LC, Griffin LC, Latham JA, et al. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 1992; 355: 564-566.
-
(1992)
Nature
, vol.355
, pp. 564-566
-
-
Bock, L.C.1
Griffin, L.C.2
Latham, J.A.3
-
27
-
-
28544449246
-
2-(2-Br-phenyl)-8-methoxy- Benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets
-
Wu CC, Wang TW, Wang WY, et al. 2-(2-Br-phenyl)-8-methoxy- benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets. Eur J Pharmacol 2005; 527: 37-43.
-
(2005)
Eur J Pharmacol
, vol.527
, pp. 37-43
-
-
Wu, C.C.1
Wang, T.W.2
Wang, W.Y.3
-
28
-
-
33748933392
-
Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor
-
Wang WY, Wu YC, Wu CC. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor. Mol Pharmacol 2006; 70: 1380-1389.
-
(2006)
Mol Pharmacol
, vol.70
, pp. 1380-1389
-
-
Wang, W.Y.1
Wu, Y.C.2
Wu, C.C.3
-
29
-
-
33748307543
-
Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation
-
Wu CC, Teng CM. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation. Eur J Pharmacol 2006; 546: 142-147.
-
(2006)
Eur J Pharmacol
, vol.546
, pp. 142-147
-
-
Wu, C.C.1
Teng, C.M.2
-
30
-
-
0037213645
-
Evaluation of DNA aptamers directed to thrombin as potential thrombus imaging agents
-
Dougan H, Weitz JI, Stafford AR, et al. Evaluation of DNA aptamers directed to thrombin as potential thrombus imaging agents. Nucl Med Biol 2003; 30: 61-72.
-
(2003)
Nucl Med Biol
, vol.30
, pp. 61-72
-
-
Dougan, H.1
Weitz, J.I.2
Stafford, A.R.3
-
31
-
-
0034670162
-
Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1- methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist
-
Ahn HS, Foster C, Boykow G, et al. Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist. Biochem Pharmacol 2000; 60: 1425-1434.
-
(2000)
Biochem Pharmacol
, vol.60
, pp. 1425-1434
-
-
Ahn, H.S.1
Foster, C.2
Boykow, G.3
-
32
-
-
0036175589
-
Role of inflammatory mediators in thrombogenesis
-
Shebuski RJ, Kilgore KS. Role of inflammatory mediators in thrombogenesis. J Pharmacol Exp Ther 2002; 300: 729-735.
-
(2002)
J Pharmacol Exp Ther
, vol.300
, pp. 729-735
-
-
Shebuski, R.J.1
Kilgore, K.S.2
-
33
-
-
3442884607
-
P-selectin in haemostasis
-
Andre P. P-selectin in haemostasis. Br J Haematol 2004; 126: 298-306.
-
(2004)
Br J Haematol
, vol.126
, pp. 298-306
-
-
Andre, P.1
-
34
-
-
0037769793
-
Platelet P-selectin facilitates atherosclerotic lesion development
-
Burger PC, Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 2003; 101: 2661-2666.
-
(2003)
Blood
, vol.101
, pp. 2661-2666
-
-
Burger, P.C.1
Wagner, D.D.2
-
35
-
-
0033559805
-
Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin
-
Kahn ML, Nakanishi-Matsui M, Shapiro MJ, et al. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 1999; 103: 879-887.
-
(1999)
J Clin Invest
, vol.103
, pp. 879-887
-
-
Kahn, M.L.1
Nakanishi-Matsui, M.2
Shapiro, M.J.3
-
36
-
-
33645507738
-
Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis
-
Leger AJ, Jacques SL, Badar J, Kaneider NC, Derian CK, Andrade-Gordon P, Covic L, Kuliopulos A. Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis. Circulation 2006; 113: 1244-1254.
-
(2006)
Circulation
, vol.113
, pp. 1244-1254
-
-
Leger, A.J.1
Jacques, S.L.2
Badar, J.3
Kaneider, N.C.4
Derian, C.K.5
Andrade-Gordon, P.6
Covic, L.7
Kuliopulos, A.8
-
37
-
-
55249083317
-
Coordinate activation of human platelet protease-activated receptor-1 and -4 in response to subnanomolar alpha-thrombin
-
Ofosu FA, Dewar L, Craven SJ, et al. Coordinate activation of human platelet protease-activated receptor-1 and -4 in response to subnanomolar alpha-thrombin. J Biol Chem 2008; 283: 26886-26893.
-
(2008)
J Biol Chem
, vol.283
, pp. 26886-26893
-
-
Ofosu, F.A.1
Dewar, L.2
Craven, S.J.3
-
38
-
-
0036287538
-
Thrombin receptor antagonists; recent advances in PAR-1 antagonist development
-
Anderluh M, Dolenc MS. Thrombin receptor antagonists; recent advances in PAR-1 antagonist development. Curr Med Chem 2002; 9: 1229-1250.
-
(2002)
Curr Med Chem
, vol.9
, pp. 1229-1250
-
-
Anderluh, M.1
Dolenc, M.S.2
-
39
-
-
0036285450
-
Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3
-
Wu CC, Hwang TL, Liao CH, et al. Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3. Thromb Haemost 2002; 87: 1026-1033.
-
(2002)
Thromb Haemost
, vol.87
, pp. 1026-1033
-
-
Wu, C.C.1
Hwang, T.L.2
Liao, C.H.3
-
40
-
-
0042563229
-
The role of PAR4 in thrombin-induced thromboxane production in human platelets
-
Wu CC, Hwang TL, Liao CH, et al. The role of PAR4 in thrombin-induced thromboxane production in human platelets. Thromb Haemost 2003; 90: 299-308.
-
(2003)
Thromb Haemost
, vol.90
, pp. 299-308
-
-
Wu, C.C.1
Hwang, T.L.2
Liao, C.H.3
-
41
-
-
0026598494
-
Thrombin-specific inhibition by and slow cleavage of hirulog-1
-
Witting JI, Bourdon P, Brezniak DV, et al. Thrombin-specific inhibition by and slow cleavage of hirulog-1. Biochem J 1992; 283: 737-743.
-
(1992)
Biochem J
, vol.283
, pp. 737-743
-
-
Witting, J.I.1
Bourdon, P.2
Brezniak, D.V.3
-
42
-
-
0028797819
-
Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system
-
Bouton MC, Jandrot-Perrus M, Moog S, et al. Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system. Biochem J 1995; 305: 635-641.
-
(1995)
Biochem J
, vol.305
, pp. 635-641
-
-
Bouton, M.C.1
Jandrot-Perrus, M.2
Moog, S.3
-
43
-
-
0032499696
-
Cloning and characterization of human protease-activated receptor 4
-
Xu WF, Andersen H, Whitmore TE, et al. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 1998; 95: 6642-6646.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 6642-6646
-
-
Xu, W.F.1
Andersen, H.2
Whitmore, T.E.3
-
44
-
-
0035877749
-
Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib
-
Soslau G, Class R, Morgan DA, et al. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. J Biol Chem 2001; 276: 21173-21183.
-
(2001)
J Biol Chem
, vol.276
, pp. 21173-21183
-
-
Soslau, G.1
Class, R.2
Morgan, D.A.3
-
45
-
-
2442486445
-
Differential activation and inhibition of human platelet thrombin receptors by structurally distinct alpha-, beta- and gamma-thrombin
-
Soslau G, Goldenberg SJ, Class R, et al. Differential activation and inhibition of human platelet thrombin receptors by structurally distinct alpha-, beta- and gamma-thrombin. Platelets 2004; 15: 155-166.
-
(2004)
Platelets
, vol.15
, pp. 155-166
-
-
Soslau, G.1
Goldenberg, S.J.2
Class, R.3
-
46
-
-
0020505313
-
Thrombin-platelet interactions: An assessment of the roles of saturable and nonsaturable binding in platelet activation
-
Alexander RJ, Fenton JW 2nd, Detwiler TC. Thrombin-platelet interactions: an assessment of the roles of saturable and nonsaturable binding in platelet activation. Arch Biochem Biophys 1983; 222: 266-275.
-
(1983)
Arch Biochem Biophys
, vol.222
, pp. 266-275
-
-
Alexander, R.J.1
Fenton II, J.W.2
Detwiler, T.C.3
-
47
-
-
20444436800
-
Nucleic acid aptamers in therapeutic anticoagulation. Technology, development and clinical application
-
Becker RC, Rusconi C, Sullenger B. Nucleic acid aptamers in therapeutic anticoagulation. Technology, development and clinical application. Thromb Haemost 2005; 93: 1014-1020.
-
(2005)
Thromb Haemost
, vol.93
, pp. 1014-1020
-
-
Becker, R.C.1
Rusconi, C.2
Sullenger, B.3
-
48
-
-
52049111643
-
Anti-coagulant aptamers
-
Gopinath SC. Anti-coagulant aptamers. Thromb Res 2008; 122: 838-847.
-
(2008)
Thromb Res
, vol.122
, pp. 838-847
-
-
Gopinath, S.C.1
|